Sponsor

Shandong Public Health Clinical Center

Clinical research sponsor

Published trials4
Recruiting shown1
Roles2
SourceClinicalTrials.gov

Clinical trials

4 shown
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLCNCT06709859 · lead sponsor · 2025-05-01
RECRUITING
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCTNCT07169903 · collaborator · 2025-10-01
NOT_YET_RECRUITING
A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in CirrhosisNCT05979935 · collaborator · 2023-07-01
ACTIVE_NOT_RECRUITING
Mesenchymal Stem Cells for Immune Non-responder Patients With HIV InfectionNCT05872659 · collaborator · 2023-04-16
UNKNOWN

Sponsor roles

collaborator3
lead sponsor1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.